Journal Article Ahead of print
PubMed: 42414046 DOI: 10.3899/jrheum.2026-0590
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 Annual Meeting.
J Rheumatol
Authors: Dafna D Gladman, Wilson Bautista-Molano, Denis Poddubnyy, William Tillett, Maarten de Wit, Alice B Gottlieb
Affiliations
- D.D. Gladman, MD, Schroeder Arthritis Institute, Toronto Western Hospital, Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- W. Bautista-Molano, MD, PhD, University Hospital Fundacion Santa Fe de Bogotá, School of Medicine, Universidad el Bosque, Bogotá, Colombia.
- D. Poddubnyy, MD, PhD, MSc, Division of Rheumatology, Department of Medicine, University of Toronto and Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.
- W. Tillett, MB ChB, PhD, Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK.
- M. de Wit, PhD, GRAPPA Patient Research Partner, Amsterdam, the Netherlands.
- A.B. Gottlieb, MD, PhD, Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas, USA.
Abstract
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 annual meeting was held from July 10 to 12, 2025, in Bogotá, Colombia. It was attended by 206 rheumatologists, dermatologists, trainees, patient research partners, representatives of patient organizations, industry partners, and others. Here we provide an overview of the workshops and symposia featured at the GRAPPA 2025 annual meeting and introduce the manuscripts published together in this supplement as a meeting report.
MeSH
Arthritis, Psoriatic, Arthritis, Rheumatic Diseases, Research, Psoriasis